The latest market report published by Credence Research, Inc. “Global Cell Culture Market: Growth, Future Prospects, and Competitive Analysis, 2023 – 2030. The global cell culture market is anticipated to grow at a substantial CAGR of 12.30% in the upcoming years. The global cell culture industry was estimated to be worth USD 21,945.6 million in 2022 and was expected to be worth USD 49,431.7 million by 2030.
The cell culture market is a dynamic and rapidly growing segment of the life sciences industry that plays a crucial role in various fields, including pharmaceuticals, biotechnology, academic research, and regenerative medicine. Cell culture involves the in vitro cultivation of cells, tissues, or organs in a controlled environment, typically within a laboratory setting. This technique enables researchers and scientists to study cell behavior, test drug candidates, develop therapies, and conduct a wide range of experiments.
One of the key drivers of the cell culture market is the increasing demand for biopharmaceuticals and vaccines. As the pharmaceutical industry shifts towards biologics and personalized medicine, cell culture techniques are integral to the production of these complex drugs. Additionally, the COVID-19 pandemic highlighted the importance of cell culture in vaccine development and manufacturing.
In terms of market segmentation, the cell culture market can be categorized based on product type, cell type, application, end-user, and region. Product types include culture media, reagents, cell culture instruments, and cell culture consumables. Cell types encompass mammalian cells, microbial cells, and insect cells, among others. Applications range from drug discovery and development to tissue engineering and regenerative medicine. End-users consist of pharmaceutical and biotechnology companies, academic and research institutions, and contract research organizations.
Technological advancements are continually shaping the cell culture market. Automation and bioreactors have revolutionized large-scale cell culture processes, enhancing efficiency and reproducibility. Furthermore, the development of three-dimensional (3D) cell culture systems has provided a more physiologically relevant environment for cell growth and differentiation.
Browse 247 pages report Global Cell Culture Market By Consumables (Media, Sera, and Reagents) By Products (Culture Systems, Incubators, Centrifuges, Cryostorage Equipment, Biosafety Equipment, and Pipetting Instruments) By Application (Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Toxicity Testing, Cancer Research, and Others)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030 - https://www.credenceresearch.com/report/cell-culture-market
Cell Culture Market Regional Analysis
North America, comprising the United States and Canada, remains a prominent player in the global cell culture market. The region boasts a well-established biotechnology and pharmaceutical industry, advanced research facilities, and a robust regulatory framework, making it a hub for cell culture-related research and production. Additionally, the presence of major pharmaceutical companies and academic institutions fuels the demand for cell culture products and services.
In Europe, countries like Germany, the United Kingdom, and France are at the forefront of cell culture research and development. These nations have a strong emphasis on healthcare and life sciences, resulting in significant investments in cell culture technologies. The European region benefits from collaborations between academia and industry, fostering innovation in cell culture methodologies.
The Asia-Pacific region, including countries like China, Japan, and India, is experiencing rapid growth in the cell culture market. Factors such as a growing biopharmaceutical industry, increasing healthcare expenditure, and a large pool of skilled labor contribute to this expansion. Emerging economies in Asia-Pacific are becoming increasingly important for contract manufacturing and research outsourcing, further driving the demand for cell culture products and services.
Latin America and the Middle East & Africa regions exhibit growing interest in cell culture applications, primarily driven by the expansion of the pharmaceutical and biotechnology sectors. However, these regions face challenges related to infrastructure, regulatory compliance, and access to advanced technologies, which may limit the pace of growth compared to more developed markets.
Cell Culture Market Partners and Acquisitions
The cell culture market has been marked by a series of significant partnerships and acquisitions, reflecting the industry's drive for innovation, market expansion, and consolidation of expertise. Thermo Fisher Scientific's acquisition of BD's Advanced Bioprocessing business in 2020 stands as a notable example. This strategic move aimed to bolster Thermo Fisher's position in the bioprocessing sector by enhancing its cell culture media and supplement offerings. It showcased how key players seek to broaden their product portfolios and capabilities to cater to the evolving demands of the life sciences and biotechnology sectors.
In another noteworthy partnership, Sartorius and Lonza joined forces in 2021. This collaboration aimed to pool their strengths in developing and commercializing novel cell culture media formulations and technologies. The partnership illustrated the importance of knowledge sharing and expertise exchange in accelerating advancements in cell culture processes, which play a pivotal role in biomanufacturing, especially in the context of biopharmaceuticals.
The acquisition of HemaCare Corporation by Charles River Laboratories in 2019 exemplifies the growing importance of cell-based therapies in the cell culture market. Charles River's move to incorporate HemaCare's cell therapy-related products and services into its offerings demonstrated the company's commitment to supporting advancements in this cutting-edge field. This strategic acquisition aimed to facilitate the development and manufacturing of cell-based therapies, which hold significant promise in the healthcare industry.
Lonza's acquisition of Cambrex in 2019 was another landmark event in the cell culture market. By integrating Cambrex, a contract development and manufacturing organization (CDMO), Lonza expanded its capabilities in cell and gene therapy manufacturing, including cell culture services. This acquisition allowed Lonza to respond effectively to the escalating demand for advanced therapies, underscoring the importance of securing the necessary expertise and resources to address emerging market needs.
Why to Buy This Report-
· The report provides a qualitative as well as quantitative analysis of the global Cell Culture Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.
· The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.
· Major nations in each region with their import/export statistics
· The global Cell Culture Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.
Browse Complete Report- https://www.credenceresearch.com/report/cell-culture-market
Visit our Website- https://www.credenceresearch.com
Related Reports- https://www.credenceresearch.com/report/brazil-data-center-market
https://www.credenceresearch.com/report/digital-transformation-market
Browse Our Blog- https://hackmd.io/@vanshikashukla/cell-culture-market
About Us -
Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.
Contact Us:
Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India
Comments